| |
Training set |
Validation set |
| Number of patients |
14 (paired samples) |
8 (unpaired samples) |
| Median age (year) |
49.5 |
55 |
| Gender |
|
|
| Female |
13 (93%) |
7 (88%) |
| Male |
1 (7%) |
1 (12%) |
| Primary tumor location |
|
|
| Unilateral |
10 (71.4%) |
8 (100%) |
| Bilateral |
4 (28.6%) |
0 (0%) |
| Surgery |
|
|
| Total thyroidectomy |
13 (93%) |
8 (100%) |
| Lobectomy |
1 (7%) |
0 (0%) |
Pathologic stage,
1 AJCC |
|
|
Age<45
Stage I
T1bN0
T3N1a
Stage III
Age ≥ 45 |
1 (7.1%)
3 (21.4%) |
0
1 (50.0%) |
| Stage I |
|
|
| T1aN0
Stage III |
3 (21.4%) |
0 |
| T3N0 |
3 (21.4%) |
1 (50.0%) |
| T3N1a |
4 (28.6%) |
0 |
1AJCC, American Joint Committee on Cancer (7th Edition) |
